Sign in

CIK 0001743881

  • Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,117,307
in 3 filings, $5.1M under 10b5-1 plans

Net −$5,117,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-01-02 Kumar Neil Director Sale −100 $35.17 $4K 2,969,311
2020-01-02 STEPHENSON BRIAN C Sale −2,295 $32.57 $75K 367,621
2020-01-02 STEPHENSON BRIAN C Sale −4,217 $33.47 $141K 363,404
2020-01-02 STEPHENSON BRIAN C Sale −622 $34.23 $21K 362,782
2020-01-02 STEPHENSON BRIAN C Sale −30 $35.17 $1K 362,752
2020-01-01 KKR Management Holdings L.P. 10% owner Other disposition −36,900,661 0
2019-12-30 MCCORMICK FRANK Chairman of Oncology Sale −16,250 $35.74 $581K 1,262,426
2019-12-30 MCCORMICK FRANK Chairman of Oncology Sale −900 $36.86 $33K 1,261,526
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −25,531 $36.37 $929K 1,335,895
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −21,656 $36.85 $798K 1,314,239
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −3,500 $38.09 $133K 1,310,739
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −13,705 $39.27 $538K 1,297,034
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −16,858 $40.13 $676K 1,280,176
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −883 $41.31 $36K 1,279,293
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −617 $42.26 $26K 1,278,676
2019-12-27 MCCORMICK FRANK Chairman of Oncology Sale −100 $42.93 $4K 1,278,576
2019-12-12 SCHELLER RICHARD H Director Grant or award · Stock Option (right to buy) +82,878 82,878
2019-12-12 YAU YI CHING Chief Accounting Officer Grant or award · Restricted Stock Units +55,652 55,652
2019-12-12 Stolz Brian M. Chief Operating Officer Grant or award · Restricted Stock Units +72,696 72,696
2019-12-12 MOMTAZEE JAMES C Director Grant or award · Stock Option (right to buy) +82,878 82,878

Page 56 of 61 · 1,201 trades